57 related articles for article (PubMed ID: 30102646)
1. Practice patterns for the management of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): an international survey by the Global NLPHL One Working Group (GLOW).
Lo AC; Major A; Super L; Appel B; Shankar A; Constine LS; Marks LJ; Kelly KM; Metzger ML; Buhtoiarov IN; Mauz-Körholz C; Costa ARS; Binkley MS; Flerlage J
Leuk Lymphoma; 2022 Aug; 63(8):1997-2000. PubMed ID: 35357263
[No Abstract] [Full Text] [Related]
2. Relapsed or poorly responsive nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents - a report from the United Kingdom's Children's Cancer and Leukaemia Study Group.
Shankar AG; Kirkwood AA; Depani S; Bianchi E; Hayward J; Ramsay AD; Hall GW
Br J Haematol; 2016 May; 173(3):421-31. PubMed ID: 26996288
[TBL] [Abstract][Full Text] [Related]
3. Impact of active surveillance at time of diagnosis on overall survival in nodular lymphocyte-predominant Hodgkin lymphoma: A National Cancer Database study.
Rogness VM; Wei W; Cortese M; Hill BT
Leuk Res; 2023 Nov; 134():107402. PubMed ID: 37778305
[No Abstract] [Full Text] [Related]
4. Adult nodular lymphocyte-predominant Hodgkin lymphoma: treatment modality utilization and survival.
Alonso C; Dutta SW; Mitra N; Landsburg DJ; Zaorsky NG; Grover S; Peterson J; Trifiletti DM
Cancer Med; 2018 Apr; 7(4):1118-1126. PubMed ID: 29479868
[TBL] [Abstract][Full Text] [Related]
5. Advanced stage nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents: clinical characteristics and treatment outcome - a report from the SFCE & CCLG groups.
Shankar AG; Roques G; Kirkwood AA; Lambilliotte A; Freund K; Leblanc T; Hayward J; Abbou S; Ramsay AD; Schmitt C; Gorde-Grosjean S; Pacquement H; Haouy S; Boudjemaa S; Aladjidi N; Hall GW; Landman-Parker J
Br J Haematol; 2017 Apr; 177(1):106-115. PubMed ID: 28220934
[TBL] [Abstract][Full Text] [Related]
6. Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Rare Lymphoma with Isolated Hepatic Presentation.
Freitas BD; Salgadinho Machado A; Lagarto M; Araújo I; Fonseca C
Eur J Case Rep Intern Med; 2023; 10(11):004061. PubMed ID: 37920229
[TBL] [Abstract][Full Text] [Related]
7. Cavitary Hodgkin Lymphoma of the Lung.
Agudile EP; Elkhawas I; Solangi Z; Schembri F; Manzoor K
Cureus; 2024 Apr; 16(4):e58152. PubMed ID: 38741830
[TBL] [Abstract][Full Text] [Related]
8. Digital pathology in pediatric nodular lymphocyte-predominant Hodgkin lymphoma: correlation with treatment response.
Sereda S; Shankar A; Weber L; Ramsay AD; Hall GW; Hayward J; Wallace WHB; Landman-Parker J; Braeuninger A; Hasenclever D; Schneider A; Mauz-Koerholz C; Koerholz D; Gattenloehner S
Blood Adv; 2023 Oct; 7(20):6285-6289. PubMed ID: 37611165
[TBL] [Abstract][Full Text] [Related]
9. Nodular lymphocyte predominant Hodgkin lymphoma: An unusual case with peripheral blood atypical T-cell lymphocytosis.
Gupta R; Gupta P; Gupta K; Chandra D; Singh MK; Arora N; Rahman K
Int J Lab Hematol; 2023 Aug; 45(4):586-588. PubMed ID: 36710455
[No Abstract] [Full Text] [Related]
10. Diffuse large B-cell lymphoma presenting with cavitary lung disease.
Hibino Y; Imai R; Jinta T
Respirol Case Rep; 2020 Jul; 8(5):e00584. PubMed ID: 32405417
[TBL] [Abstract][Full Text] [Related]
11. Multiloculated Cavitary Primary Pulmonary Hodgkin Lymphoma: Case Series.
Aljehani Y; Al-Saif H; Al-Osail A; Al-Osail E
Case Rep Oncol; 2018; 11(1):90-97. PubMed ID: 29606947
[TBL] [Abstract][Full Text] [Related]
12. Investigational use of PEGylated carboxyhemoglobin bovine in a Jehovah's Witness with hemorrhagic shock.
DeSimone RA; Berlin DA; Avecilla ST; Goss CA
Transfusion; 2018 Oct; 58(10):2297-2300. PubMed ID: 30203845
[TBL] [Abstract][Full Text] [Related]
13. Successful Response to Osimertinib Rechallenge after Intervening Chemotherapy in an EGFR T790M-Positive Lung Cancer Patient.
Metro G; Baglivo S; Siggillino A; Ludovini V; Chiari R; Rebonato A; Bellezza G
Clin Drug Investig; 2018 Oct; 38(10):983-987. PubMed ID: 30151614
[TBL] [Abstract][Full Text] [Related]
14. Preventing central nervous system metastases in non-small cell lung cancer.
Krawczyk P; Duchnowska R; Nicoś M; Kowalski D; Wojas-Krawczyk K
Expert Rev Anticancer Ther; 2018 Nov; 18(11):1077-1083. PubMed ID: 30198357
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and treatment dilemma during the coronavirus disease 2019 pandemic: a primary pulmonary lymphoma presenting as a cavitary mass in a patient with coronavirus disease 2019: a case report.
Wong F; Doyle-McClam M; Pugh S; Dudney T; McCormack M; Kravitz J
J Med Case Rep; 2023 Jan; 17(1):12. PubMed ID: 36635758
[TBL] [Abstract][Full Text] [Related]
16. Multiple Cavitary Lung Lesions in an Adolescent: Case Report of a Rare Presentation of Nodular Lymphocyte Predominant Hodgkin Lymphoma.
Soliman M; Neemuchwala F; Sankar A; Jasty R; Rabah R; Popova AP; Newman EA
J Pediatr Hematol Oncol; 2018 Oct; 40(7):e454-e457. PubMed ID: 30102646
[TBL] [Abstract][Full Text] [Related]
17. Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma.
Boudová L; Torlakovic E; Delabie J; Reimer P; Pfistner B; Wiedenmann S; Diehl V; Müller-Hermelink HK; Rüdiger T
Blood; 2003 Nov; 102(10):3753-8. PubMed ID: 12881319
[TBL] [Abstract][Full Text] [Related]
18. [Nodular lymphocyte-predominant Hodgkin lymphoma in children: clinical course, biology, and management].
Gorde-Grosjean S; Guimard G; Lambilliotte A; Coulomb-Lhermine A; Montravers F; Landman-Parker J
Bull Cancer; 2014 Sep; 101(9):881-90. PubMed ID: 25296072
[TBL] [Abstract][Full Text] [Related]
19. Immunoarchitectural patterns in nodular lymphocyte predominant Hodgkin lymphoma: pathologic and clinical implications.
Gloghini A; Bosco A; Ponzoni M; Spina M; Carbone A
Expert Rev Hematol; 2015 Apr; 8(2):217-23. PubMed ID: 25487651
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
